The Medicines Classification Committee recommends not following Australia in easing restrictions on low-dose cannabidiol, but a Hamilton-based pharmacist says it’s a missed opportunity
Nearly 1,500 New Zealand doctors and pharmacists have now registered on MCinfo.com – a dedicated and comprehensive medicinal cannabis information service
There’s a dearth of high-quality studies on medicinal cannabis but plenty of anecdotal evidence that medicinal cannabis works for a range of conditions, says a doctor specialising in the field
Specialist GP Graham Gulbransen would like to see standard prescription medicines substituted with medicinal cannabis, with growing evidence showing benefits for a range of health conditions
We are on our summer break and the editorial office is closed until 17 January. In the meantime, please enjoy our Summer Hiatus series, an eclectic mix from our news and clinical archives and articles from The Conversation throughout the year
From today New Zealanders will be able to request access to medicinal cannabis dried flower for the first time ever, after leading medicinal cannabis company Australian Natural Therapeutics Group (ANTG) has been granted the green light to ship its locally cultivated product to New Zealand
Two Helius products herald the arrival of the long-promised New Zealand-made cannabidiol products. Steve Hart talks to a Waikato pharmacist who is pleased to see prices falling as a result
For the last decade, Martin Woodbridge has worked with regulators, and industry and health professionals to promote the rational use of cannabis-based medicines. Here, he considers the introduction of cannabis-based medicines to New Zealand and explores what it means for pharmacy practice
Two Helius products herald the arrival of the long-promised New Zealand-made cannabidiol products. Steve Hart talks to a Waikato pharmacist who is pleased to see prices falling as a result